Patent Application
20230040709
The carbon-oxygen (C—O) bond-forming reactions are of particular interest in the field of organic synthesis, as C—O bonds are prevalent in many natural products, pharmaceuticals, and agrochemicals. Although Pd-based C—O cross-coupling catalysts are well established, there has been a great interest in developing sustainable alternate catalytic systems based on earth-abundant nickel. In this regard, photoredox/nickel dual catalysis and light-promoted Ni catalysis have emerged as powerful strategies for challenging C—O bond formations. Accordingly, an in-depth mechanistic understanding of Ni-mediated photocatalysis is essential for rational reaction design and optimization. From a mechanistic viewpoint, while the photocatalytic cycle is well-understood, the Ni-mediated redox cycle remains elusive as intermediates in various oxidation states (from Ni0 to NiIV) have been proposed (Trends Chem. 2019, 1, 830). For example, the involvement of paramagnetic NiI and NiIII species has been commonly implicated, yet such intermediates have not been thoroughly investigated.
Our group has employed tetradentate azamacrocycle N,N′-dialkyl-2,11-diaza[3.3](2,6)pyridinophanes (RN4) ligands to isolate and characterize NiIII species capable of C—C and C-heteroatom bond formation reactions, and to probe involvement of different high-valent Ni species in these reactions (J. Am. Chem. Soc. 2014, 136, 6499). However, considering that the most ubiquitous ligand systems in Ni cross-coupling and photocatalysis are the bidentate bipyridine ligands, the RN4 ligands are less effective owing to the crowded environment around the Ni center, which is also expected to hinder the formation of NiI species. By contrast, a bidentate ligand structure is not suitable for stabilizing high-valent Ni species, thus hampering the investigation of such Ni intermediates.
Also, other known fac-capping tridentate N-donor ligands, such as tris(pyrazoyl)borate (Tp−), tris(pyrazolyl)methane (Tpm), or 1,4,7-trimethyl-1,4,7-triazacyclononane (Me3TACN) have been reported, yet they have a large degree of flexibility due to the absence of bridges between the donor atoms (Tp− or Tpm), or they are fully aliphatic macrocycles (TACN).
Accordingly, there is a need for new efficient and cost-effective catalysts to further advance the field of chemical synthesis.
Considering the challenges of carbon-oxygen bond-forming reactions, we sought to identify an optimal ligand framework positioned in between bipyridine and RN4 ligands in terms of denticity, molecular structure, and functionality, and thus the pyridinophane tridentate RN3 ligands were targeted (Scheme 1a). These RN3 ligands are structurally analogous to the RN4 ligands, possessing a rigid aromatic pyridinophane framework and containing only one flexible chelating arm that allows for either a κ2 or κ3 coordination. Surprisingly, such RN3 ligands have never been synthesized to date, likely due to the lack of an efficient synthetic route.
In this work, we report the development of new N-alkyl-2-aza[3.2](2,6)pyridionphanes (RN3, R=Me or iPr) ligands, which embody our design criteria for photocatalytic applications and mechanistic studies. The corresponding (RN3)Ni complexes are active C—O cross-coupling catalysts upon light excitation and without an added precious-metal photocatalyst. Importantly, we show that the utilization of the tridentate RN3 ligands allows a comprehensive examination of the Ni intermediates proposed in the individual steps of the cross-coupling catalytic cycle: oxidative addition, transmetalation/ligand exchange, and reductive elimination, all these steps involving paramagnetic NiI or NiIII species.
Accordingly, this disclosure provides an organometallic compound of Formula I:
wherein
M is a transition metal;
L is a ligand and n is 1, 2, or 3;
R1 is —(C1-C6)alkyl, or —(C3-C6)cycloalkyl; and
R2 and R3 are each independently H, halo, —(C1-C6)alkyl, —(C3-C6)cycloalkyl, —O(C1-C6)alkyl, or —N[(C1-C6)alkyl]2;
wherein each (C1-C6)alkyl moiety is independently unbranched or branched.
This disclosure also provides a macrocyclic compound of Formula II:
wherein
R1 is —(C1-C6)alkyl, —(C3-C6)cycloalkyl, or sulfonyl; and
R2 and R3 are each independently H, halo, —(C1-C6)alkyl, —(C3-C6)cycloalkyl, —O(C1-C6)alkyl, or —N[(C1-C6)alkyl]2;
wherein each (C1-C6)alkyl moiety is independently unbranched or branched.
Additionally, this disclosure provides a method for preparing a pyridinophane comprising:
wherein
wherein R1, R2, and R3 is defined for Formula III.
The invention provides novel compounds of Formulas I, II, IIB, and III intermediates for the synthesis of compounds of Formulas I, II, IIB, and III, as well as methods of preparing compounds of Formulas I, II, IIB, and III. The invention also provides compounds of Formulas I, II, IIB, and III that are useful as intermediates for the synthesis of other useful compounds. The invention provides for the use of compounds of Formulas I, II, IIB, and III for the manufacture of catalysts useful for cross-coupling reactions, such as carbon-oxygen bond-forming reactions. The invention provides for the use of compositions described herein for use in preparing reagents for cross-coupling reactions.
The following drawings form part of the specification and are included to further demonstrate certain embodiments or various aspects of the invention. In some instances, embodiments of the invention can be best understood by referring to the accompanying drawings in combination with the detailed description presented herein. The description and accompanying drawings may highlight a certain specific example, or a certain aspect of the invention. However, one skilled in the art will understand that portions of the example or aspect may be used in combination with other examples or aspects of the invention.
Photoredox catalysis has emerged as a powerful strategy for C—O cross-coupling reactions. Although the involvement of paramagnetic Ni(I) and Ni(III) species as active intermediates in the catalytic cycle has been proposed, a thorough spectroscopic investigation of these species is lacking. We herein report a new class of tridentate pyridinophane ligands RN3 that allow for detailed mechanistic studies of the photocatalytic C—O coupling reaction. The derived (RN3)Ni complexes are active C—O cross-coupling photocatalysts under mild conditions and without an additional photocatalyst. We also utilized the RN3 ligands to study the essential but so far putative steps involving paramagnetic Ni species in the proposed catalytic cycle: the oxidative addition of an aryl bromide to a Ni(I) species, the ligand exchange at a Ni(III) center, and the C—O reductive elimination from a Ni(III) species. The present work also suggests these RN3 ligands are a practical platform for mechanistic studies of related Ni-catalyzed reactions.
In addition to the Ni complexes, other transition metal complexes supported by the RN3 ligands should also exhibit new reactivity. Based on the coordination flexibility of the RN3 type ligand to accommodate metal ions having different sizes and oxidation states, we expect that a variety of other transition metal ions such as Cu, Co, Zn, Fe, Mn, Pd, Ru, Rh can also be readily supported. As such, the potentially rich chemistry of these complexes in many applications is expected, from small molecule activation (such as O2, H2, CO2, and H2), catalytic oxidation reactions, olefin polymerization catalysis, new compounds with desired photophysical properties.
Additional information and data supporting the invention can be found in the following publication: Nat. Commun. 13, 1313 (2022) and its Supporting Information, which is incorporated herein by reference in its entirety.
The following definitions are included to provide a clear and consistent understanding of the specification and claims. As used herein, the recited terms have the following meanings. All other terms and phrases used in this specification have their ordinary meanings as one of skill in the art would understand. Such ordinary meanings may be obtained by reference to technical dictionaries, such as Hawley's Condensed Chemical Dictionary 14th Edition, by R. J. Lewis, John Wiley & Sons, New York, N.Y., 2001.
References in the specification to “one embodiment”, “an embodiment”, etc., indicate that the embodiment described may include a particular aspect, feature, structure, moiety, or characteristic, but not every embodiment necessarily includes that aspect, feature, structure, moiety, or characteristic. Moreover, such phrases may, but do not necessarily, refer to the same embodiment referred to in other portions of the specification. Further, when a particular aspect, feature, structure, moiety, or characteristic is described in connection with an embodiment, it is within the knowledge of one skilled in the art to affect or connect such aspect, feature, structure, moiety, or characteristic with other embodiments, whether or not explicitly described.
The singular forms “a,” “an,” and “the” include plural reference unless the context clearly dictates otherwise. Thus, for example, a reference to “a compound” includes a plurality of such compounds, so that a compound X includes a plurality of compounds X. It is further noted that the claims may be drafted to exclude any optional element. As such, this statement is intended to serve as antecedent basis for the use of exclusive terminology, such as “solely,” “only,” and the like, in connection with any element described herein, and/or the recitation of claim elements or use of “negative” limitations.
The term “and/or” means any one of the items, any combination of the items, or all of the items with which this term is associated. The phrases “one or more” and “at least one” are readily understood by one of skill in the art, particularly when read in context of its usage. For example, the phrase can mean one, two, three, four, five, six, ten, 100, or any upper limit approximately 10, 100, or 1000 times higher than a recited lower limit. For example, one or more substituents on a phenyl ring refers to one to five, or one to four, for example if the phenyl ring is disubstituted.
As will be understood by the skilled artisan, all numbers, including those expressing quantities of ingredients, properties such as molecular weight, reaction conditions, and so forth, are approximations and are understood as being optionally modified in all instances by the term “about.” These values can vary depending upon the desired properties sought to be obtained by those skilled in the art utilizing the teachings of the descriptions herein. It is also understood that such values inherently contain variability necessarily resulting from the standard deviations found in their respective testing measurements. When values are expressed as approximations, by use of the antecedent “about,” it will be understood that the particular value without the modifier “about” also forms a further aspect.
The terms “about” and “approximately” are used interchangeably. Both terms can refer to a variation of ±5%, ±10%, ±20%, or ±25% of the value specified. For example, “about 50” percent can in some embodiments carry a variation from 45 to 55 percent, or as otherwise defined by a particular claim. For integer ranges, the term “about” can include one or two integers greater than and/or less than a recited integer at each end of the range. Unless indicated otherwise herein, the terms “about” and “approximately” are intended to include values, e.g., weight percentages, proximate to the recited range that are equivalent in terms of the functionality of the individual ingredient, composition, or embodiment. The terms “about” and “approximately” can also modify the endpoints of a recited range as discussed above in this paragraph.
As will be understood by one skilled in the art, for any and all purposes, particularly in terms of providing a written description, all ranges recited herein also encompass any and all possible sub-ranges and combinations of sub-ranges thereof, as well as the individual values making up the range, particularly integer values. It is therefore understood that each unit between two particular units are also disclosed. For example, if 10 to 15 is disclosed, then 11, 12, 13, and 14 are also disclosed, individually, and as part of a range. A recited range (e.g., weight percentages or carbon groups) includes each specific value, integer, decimal, or identity within the range. Any listed range can be easily recognized as sufficiently describing and enabling the same range being broken down into at least equal halves, thirds, quarters, fifths, or tenths. As a non-limiting example, each range discussed herein can be readily broken down into a lower third, middle third and upper third, etc. As will also be understood by one skilled in the art, all language such as “up to”, “at least”, “greater than”, “less than”, “more than”, “or more”, and the like, include the number recited and such terms refer to ranges that can be subsequently broken down into sub-ranges as discussed above. In the same manner, all ratios recited herein also include all sub-ratios falling within the broader ratio. Accordingly, specific values recited for radicals, substituents, and ranges, are for illustration only; they do not exclude other defined values or other values within defined ranges for radicals and substituents. It will be further understood that the endpoints of each of the ranges are significant both in relation to the other endpoint, and independently of the other endpoint.
This disclosure provides ranges, limits, and deviations to variables such as volume, mass, percentages, ratios, etc. It is understood by an ordinary person skilled in the art that a range, such as “number1” to “number2”, implies a continuous range of numbers that includes the whole numbers and fractional numbers. For example, 1 to 10 means 1, 2, 3, 4, 5, . . . 9, 10. It also means 1.0, 1.1, 1.2. 1.3, . . . , 9.8, 9.9, 10.0, and also means 1.01, 1.02, 1.03, and so on. If the variable disclosed is a number less than “number10”, it implies a continuous range that includes whole numbers and fractional numbers less than number10, as discussed above. Similarly, if the variable disclosed is a number greater than “number10”, it implies a continuous range that includes whole numbers and fractional numbers greater than number10. These ranges can be modified by the term “about”, whose meaning has been described above.
One skilled in the art will also readily recognize that where members are grouped together in a common manner, such as in a Markush group, the invention encompasses not only the entire group listed as a whole, but each member of the group individually and all possible subgroups of the main group. Additionally, for all purposes, the invention encompasses not only the main group, but also the main group absent one or more of the group members. The invention therefore envisages the explicit exclusion of any one or more of members of a recited group. Accordingly, provisos may apply to any of the disclosed categories or embodiments whereby any one or more of the recited elements, species, or embodiments, may be excluded from such categories or embodiments, for example, for use in an explicit negative limitation.
The term “contacting” refers to the act of touching, making contact, or of bringing to immediate or close proximity, including at the cellular or molecular level, for example, to bring about a physiological reaction, a chemical reaction, or a physical change, e.g., in a solution, in a reaction mixture, in vitro, or in vivo.
An “effective amount” refers to an amount effective to bring about a recited effect, such as an amount necessary to form products in a reaction mixture. Determination of an effective amount is typically within the capacity of persons skilled in the art, especially in light of the detailed disclosure provided herein. The term “effective amount” is intended to include an amount of a compound or reagent described herein, or an amount of a combination of compounds or reagents described herein, e.g., that is effective to form products in a reaction mixture. Thus, an “effective amount” generally means an amount that provides the desired effect.
The term “substantially” as used herein, is a broad term and is used in its ordinary sense, including, without limitation, being largely but not necessarily wholly that which is specified. For example, the term could refer to a numerical value that may not be 100% the full numerical value. The full numerical value may be less by about 1%, about 2%, about 3%, about 4%, about 5%, about 6%, about 7%, about 8%, about 9%, about 10%, about 15%, or about 20%.
Wherever the term “comprising” is used herein, options are contemplated wherein the terms “consisting of” or “consisting essentially of” are used instead. As used herein, “comprising” is synonymous with “including,” “containing,” or “characterized by,” and is inclusive or open-ended and does not exclude additional, unrecited elements or method steps. As used herein, “consisting of” excludes any element, step, or ingredient not specified in the aspect element. As used herein, “consisting essentially of” does not exclude materials or steps that do not materially affect the basic and novel characteristics of the aspect. In each instance herein any of the terms “comprising”, “consisting essentially of” and “consisting of” may be replaced with either of the other two terms. The disclosure illustratively described herein may be suitably practiced in the absence of any element or elements, limitation or limitations which is not specifically disclosed herein.
This disclosure provides methods of making the compounds and compositions of the invention. The compounds and compositions can be prepared by any of the applicable techniques described herein, optionally in combination with standard techniques of organic synthesis. Many techniques such as etherification and esterification are well known in the art. However, many of these techniques are elaborated in Compendium of Organic Synthetic Methods (John Wiley & Sons, New York), Vol. 1, Ian T. Harrison and Shuyen Harrison, 1971; Vol. 2, Ian T. Harrison and Shuyen Harrison, 1974; Vol. 3, Louis S. Hegedus and Leroy Wade, 1977; Vol. 4, Leroy G. Wade, Jr., 1980; Vol. 5, Leroy G. Wade, Jr., 1984; and Vol. 6; as well as standard organic reference texts such as March's Advanced Organic Chemistry: Reactions, Mechanisms, and Structure, 5th Ed., by M. B. Smith and J. March (John Wiley & Sons, New York, 2001); Comprehensive Organic Synthesis. Selectivity, Strategy & Efficiency in Modern Organic Chemistry. In 9 Volumes, Barry M. Trost, Editor-in-Chief (Pergamon Press, New York, 1993 printing); Advanced Organic Chemistry, Part B: Reactions and Synthesis, Second Ed., Cary and Sundberg (1983); for heterocyclic synthesis see Hermanson, Greg T., Bioconjugate Techniques, Third Ed., Academic Press, 2013.
The formulas and compounds described herein can be modified using protecting groups. Suitable amino and carboxy protecting groups are known to those skilled in the art (see for example, Protecting Groups in Organic Synthesis, Second Edition, Greene, T. W., and Wutz, P. G. M., John Wiley & Sons, New York, and references cited therein; Philip J. Kocienski; Protecting Groups (Georg Thieme Verlag Stuttgart, New York, 1994), and references cited therein); and Comprehensive Organic Transformations, Larock, R. C., Second Edition, John Wiley & Sons, New York (1999), and referenced cited therein.
The term “halo” or “halide” refers to fluoro, chloro, bromo, or iodo. Similarly, the term “halogen” refers to fluorine, chlorine, bromine, and iodine.
The term “alkyl” refers to a branched or unbranched hydrocarbon having, for example, from 1-20 carbon atoms, and often 1-12, 1-10, 1-8, 1-6, or 1-4 carbon atoms; or for example, a range between 1-20 carbon atoms, such as 2-6, 3-6, 2-8, or 3-8 carbon atoms. As used herein, the term “alkyl” also encompasses a “cycloalkyl”, defined below. Examples include, but are not limited to, methyl, ethyl, 1-propyl, 2-propyl (iso-propyl), 1-butyl, 2-methyl-1-propyl (isobutyl), 2-butyl (sec-butyl), 2-methyl-2-propyl (t-butyl), 1-pentyl, 2-pentyl, 3-pentyl, 2-methyl-2-butyl, 3-methyl-2-butyl, 3-methyl-1-butyl, 2-methyl-1-butyl, 1-hexyl, 2-hexyl, 3-hexyl, 2-methyl-2-pentyl, 3-methyl-2-pentyl, 4-methyl-2-pentyl, 3-methyl-3-pentyl, 2-methyl-3-pentyl, 2,3-dimethyl-2-butyl, 3,3-dimethyl-2-butyl, hexyl, octyl, decyl, dodecyl, and the like. The alkyl can be unsubstituted or substituted, for example, with a substituent described below or otherwise described herein. The alkyl can also be optionally partially or fully unsaturated. As such, the recitation of an alkyl group can include an alkenyl group or an alkynyl group. The alkyl can be a monovalent hydrocarbon radical, as described and exemplified above, or it can be a divalent hydrocarbon radical (i.e., an alkylene).
An alkylene is an alkyl group having two free valences at a carbon atom or two different carbon atoms of a carbon chain. Similarly, alkenylene and alkynylene are respectively an alkene and an alkyne having two free valences at two different carbon atoms.
The term “cycloalkyl” refers to cyclic alkyl groups of, for example, from 3 to 10 carbon atoms having a single cyclic ring or multiple condensed rings. Cycloalkyl groups include, by way of example, single ring structures such as cyclopropyl, cyclobutyl, cyclopentyl, cyclooctyl, and the like, or multiple ring structures such as adamantyl, and the like. The cycloalkyl can be unsubstituted or substituted. The cycloalkyl group can be monovalent or divalent, and can be optionally substituted as described for alkyl groups. The cycloalkyl group can optionally include one or more cites of unsaturation, i.e., the cycloalkyl group can include one or more carbon-carbon double bonds, such as, for example, 1-cyclopent-1-enyl, 1-cyclopent-2-enyl, 1-cyclopent-3-enyl, cyclohexyl, 1-cyclohex-1-enyl, 1-cyclohex-2-enyl, 1-cyclohex-3-enyl, and the like.
The term “heterocycloalkyl” or “heterocyclyl” refers to a saturated or partially saturated monocyclic, bicyclic, or polycyclic ring containing at least one heteroatom selected from nitrogen, sulfur, oxygen, preferably from 1 to 3 heteroatoms in at least one ring. Each ring is preferably from 3 to 10 membered, more preferably 4 to 7 membered. Examples of suitable heterocycloalkyl substituents include pyrrolidyl, tetrahydrofuryl, tetrahydrothiofuranyl, piperidyl, piperazyl, tetrahydropyranyl, morpholino, 1,3-diazapane, 1,4-diazapane, 1,4-oxazepane, and 1,4-oxathiapane. The group may be a terminal group or a bridging group.
The term “aromatic” refers to either an aryl or heteroaryl group or substituent described herein. Additionally, an aromatic moiety may be a bisaromatic moiety, a trisaromatic moiety, and so on. A bisaromatic moiety has a single bond between two aromatic moieties such as, but not limited to, biphenyl and bipyridine. Similarly, a trisaromatic moiety has a single bond between each aromatic moiety.
The term “aryl” refers to an aromatic hydrocarbon group derived from the removal of at least one hydrogen atom from a single carbon atom of a parent aromatic ring system. The radical attachment site can be at a saturated or unsaturated carbon atom of the parent ring system. The aryl group can have from 6 to 30 carbon atoms, for example, about 6-10 carbon atoms. The aryl group can have a single ring (e.g., phenyl) or multiple condensed (fused) rings, wherein at least one ring is aromatic (e.g., naphthyl, dihydrophenanthrenyl, fluorenyl, or anthryl). Typical aryl groups include, but are not limited to, radicals derived from benzene, naphthalene, anthracene, biphenyl, and the like. The aryl can be unsubstituted or optionally substituted with a substituent described below.
The term “heteroaryl” refers to a monocyclic, bicyclic, or tricyclic ring system containing one, two, or three aromatic rings and containing at least one nitrogen, oxygen, or sulfur atom in an aromatic ring. The heteroaryl can be unsubstituted or substituted, for example, with one or more, and in particular one to three, substituents, as described in the definition of “substituted”. Typical heteroaryl groups contain 2-20 carbon atoms in the ring skeleton in addition to the one or more heteroatoms, wherein the ring skeleton comprises a 5-membered ring, a 6-membered ring, two 5-membered rings, two 6-membered rings, or a 5-membered ring fused to a 6-membered ring.
As used herein, the term “substituted” or “substituent” is intended to indicate that one or more (for example, in various embodiments, 1-10; in other embodiments, 1-6; in some embodiments 1, 2, 3, 4, or 5; in certain embodiments, 1, 2, or 3; and in other embodiments, 1 or 2) hydrogens on the group indicated in the expression using “substituted” (or “substituent”) is replaced with a selection from the indicated group(s), or with a suitable group known to those of skill in the art, provided that the indicated atom's normal valency is not exceeded, and that the substitution results in a stable compound. Suitable indicated groups include, e.g., alkyl, alkenyl, alkynyl, alkoxy, haloalkyl, hydroxyalkyl, aryl, heteroaryl, heterocyclyl, cycloalkyl, alkanoyl, alkoxycarbonyl, amino, alkylamino, dialkylamino, carboxyalkyl, alkylthio, alkylsulfinyl, and alkylsulfonyl. Substituents of the indicated groups can be those recited in a specific list of substituents described herein, or as one of skill in the art would recognize, can be one or more substituents selected from alkyl, alkenyl, alkynyl, alkoxy, halo, haloalkyl, hydroxy, hydroxyalkyl, aryl, heteroaryl, heterocycle, cycloalkyl, alkanoyl, alkoxycarbonyl, amino, alkylamino, dialkylamino, trifluoromethylthio, difluoromethyl, acylamino, nitro, trifluoromethyl, trifluoromethoxy, carboxy, carboxyalkyl, keto, thioxo, alkylthio, alkylsulfinyl, alkylsulfonyl, and cyano.
This disclosure provides an organometallic compound of Formula I:
wherein
M is a transition metal;
L is a ligand and n is 1, 2, 3, 4, or 5;
R1 is —(C1-C6)alkyl, —(C3-C6)cycloalkyl, or —(C1-C6)alkyl(C3-C6)cycloalkyl; and
R2 and R3 are each independently H, halo, —(C1-C6)alkyl, —(C3-C6)cycloalkyl, —O(C1-C6)alkyl, or —N[(C1-C6)alkyl]2;
wherein each (C1-C6)alkyl moiety is independently unbranched or branched.
In various embodiments, M is Ni, Cu, Co, Zn, Fe, Mn, Pd, Ru or Rh. In other embodiments, M is Ni wherein Ni is Ni (II) or Ni (III). In various embodiments, L is halo, alkyl, aryl, nitrile, acetophenone or p-acetophenone, sulfonate, sulfonyl, toluenesulfonyl or p-toluenesulfonyl, or a combination thereof. In various embodiments, n is 2 or 3. In various embodiments, aryl is optionally substituted. In various embodiments, L, R1, R2 and R3 are each independently methyl, ethyl, propyl, isopropyl, n-butyl, sec-butyl, or tert-butyl. In various embodiments, R2 and R3 are H.
In some embodiments, the compound is:
Also, this disclosure provides a macrocyclic compound of Formula II:
wherein:
In various embodiments, R1 is methyl, isopropyl, or arylsulfonyl. In various embodiments, R2 and R3 are H.
In some embodiments, the compound is:
Additionally, this disclosure provides a composition comprising a compound disclosed herein and a suitable solvent. In various embodiments, the solvent may be polar, non-polar, protic, aprotic, or a combination thereof. In various embodiments, the solvent is an ether, hydrocarbon, or a halogenated solvent. In some embodiments, the solvent is, for example, acetonitrile, tetrahydrofuran, dichloromethane, chloroform, pentane, hexane, toluene, ethanol, water, or a combination thereof when the combined solvents are miscible with each other.
In other embodiments, the compound is:
Furthermore, this disclosure provides a method for preparing a pyridinophane comprising:
wherein:
wherein R1, R2, and R3 are as defined for Formula III.
In various embodiments, R1 of the pyridinophane is para-toluenesulfonyl. In various embodiments, the protecting group is, for example, tosylate, acetate, 9-fluorenylmethyl carbamate, t-Butyl carbamate, or benzyl carbamate.
In some embodiments, the method further comprises:
c) removing the nitrogen protecting group from the pyridinophane of Formula IIB to form a secondary amine wherein R1 is H;
d) alkylating the secondary amine to form a tertiary amine wherein R1 is —(C1-C6)alkyl;
e) contacting the tertiary amine and a transition metal salt to form a transition metal complex of the pyridinophane having one or more ligands; and
f) optionally replacing ligands on the transition metal moiety of the complex with different ligands under suitable reaction conditions.
Additionally, this disclosure also provides a method for cross-coupling comprising:
In some embodiments, the organometallic compound is:
In various embodiments, the suitable reaction conditions comprise irradiating the mixture with light, a LED, or a purple light emitting diode (LED). In some embodiments, the LED emits light at a wavelength of about 390 nm.
Ligand Development. In 1958, Overberger et al. (J. Am. Chem. Soc. 1958, 80, 3009) reported the reduction of N-nitrosodibenzylamines by Na2S2O4 to generate the hydrocarbon product with evolution of N2. However, this reaction has received little attention since then, and only one report by Takemura et al. in 1988 exploited the N-nitroso reduction reaction to obtain [2.2]cyclophane derivatives (Tet. Lett. 1988, 29, 1031). We speculated that this N-extrusion reaction would provide an efficient synthetic pathway for tridentate pyridinophane ligands. Our synthesis starts with the unsymmetrical pryridinophane precursor N-tosyl-2,11-diaza[3.3](2,6)pyridionphane (TsHN4, Scheme 2a) (Org. Biomol. Chem. 2017, 15, 9923). For the nitrosylation step, TsHN4 was treated with HNO2 to generate the N-nitroso intermediate TsNON4 85% yield. Subsequent reductive elimination of dinitrogen from the nitrosamine was performed with Na2S2O4 under basic conditions, converting TsNON4 to TsN3 in 75% yield. Additional steps of detosylation and methylation or isopropylation afforded the alkylated ligand variants MeN3 or iPrN3 in ˜45% overall yields, confirming that further functionalization can be easily achieved. The N-nitroso reduction conditions are mild, suggesting a broad functional group tolerance. Since all reaction steps do not require extensive purification and their yields are high, the development of this novel synthetic route provides an opportunity to access a variety of ligand structures by further functionalization or starting from different secondary amine precursors.
Synthesis and Characterization of RN3NiCl2 Complexes. The reaction of MeN3 or iPrN3 with Ni(DME)Cl2 in CH2Cl2 generated the green NiII-dichloride complexes (MeN3)NiCl2 (1a) and (iPrN3)NiCl2 (1b), respectively (Scheme 2b). The molecular structures of 1a and 1b were determined by single crystal X-ray diffraction (
The electrochemical properties of (RN3)NiCl2 complexes were investigated by cyclic voltammetry (CV,
The accessible reduction events observed for (RN3)NiCl2 indicates that for these complexes the NiI oxidation state is accessible by one-electron reduction with a mild chemical reductant and can be exploited in reactivity and mechanistic studies. Overall, when compared to (dtbbpy)NiCl2, the (RN3)NiCl2 complexes exhibit similar oxidation and reduction potentials, which is essential for photocatalysis, yet they possess a structural advantage by containing the flexible axial amine arm that is beneficial for detailed mechanistic studies.
The UV-visible absorption spectra of 1a and 1b were then obtained and analyzed computationally. The UV-vis absorption spectrum of 1a shows an intense band around 380 nm and a less intense band around 640 nm (
For a qualitative representation of the specified transitions between the ground and excited states, we performed natural transition orbital (NTO) analysis which provides a localized picture of the transition density matrix (
Photocatalytic C—O cross-coupling mediated by (RN3)NiCl2 complexes. To probe the relevance of the (RN3)NiCl2 complexes in photocatalysis, we evaluated their light-promoted catalytic activity in C—O cross-coupling without any additional photocatalyst. Our initial efforts focused on optimizing the reaction conditions using methanol and 4-bromoacetophenone (Table 1 and Table 6-12). In the presence of 2 mol % (MeN3)NiCl2 (1a) and quinuclidine in THF, the desired C—O coupled product 4-methoxyacetophenone was obtained in 95% yield under purple LED irradiation (Table 1, entry 1). Control experiments revealed that the reaction did not proceed without Ni catalyst, light, or base (Table 1, entries 2-4). The desired product was not observed when the reaction was irradiated with blue LED, suggesting the crucial role of the excitation energy (Table 1, entry 5). While inorganic bases such as K2CO3 were not effective, possibly due to the slow proton-transfer kinetics or the precipitation of halides required to stabilize the NiI intermediate, DABCO was effective but proceeded at a slightly slower rate and thus requiring a longer reaction times (Table 1, entries 6-8). Switching from 1a to 1b or (MeN3)NiBr2, lowering of catalyst loading to 0.2 mol %, or the addition of MeN3 and Ni(DME)Cl2 separately instead of 1a gave comparable yields (Table 1, entries 9-12). Notably, a 0.2 mol % catalyst loading is significantly less (˜25-50 fold decrease) than the loadings used in other Ni-photocatalyzed C—O cross-couplings. Moreover, other alcohols such as 1-hexanol and benzyl alcohol could also be employed (Table 11, 86-90% product yield). However, the combination of 1a and heterogenous Zn0 or Mn0 without light was ineffective in our conditions, likely due to the slow electron transfer kinetics or insufficient generation of the active species during catalysis.
MeN3NiCl2 0.2 mol % instead of 2 mol %
MeN3NiBr2 instead of MeN3NiCl2
iPrN3NiCl2 instead of MeN3NiCl2
MeN3 (2 mol %) + Ni(DME)Cl2 (2 mol %)
aReaction conditions: In a N2-filled glovebox, 4-bromoacetophenone (0.4 mmol, 1.0 equiv), quinuclidine (0.44 mmol, 1.1 equiv), MeOH (1.6 mmol, 4 equiv), (MeN3Ni)Ch2 (2 mol %) and a magnetic stir bar were added into 0.4 mL THF in a vial. The vial was irradiated with one purple LED lamp (52 W, 390 nm) under fan cooling. After 24 h, 1,3-benzodioxole (0.4 mmol) was added to the reaction mixture as a standard and the residue was analyzed by 1H NMR and GC-FID to determine the yield of C—O coupled product.
The use of a Ni complex supported by another tridentate N-donor ligand 1,4,7-triosopropyl-1,4,7-triazacyclononane, (iPr3TACN)NiIICl2, generated the desired product only in a moderate yield (51%, see Ni catalyst Table 4), while the (RN4)NiIICl2 complex supported by the tetradentate ligand MeN4 yielded a negligible amount of product, validating our ligand design principle (Table 1, entry 13).
The same C—O coupling reaction was also probed under common dual Ni/photoredox catalytic conditions using various Ir or Ru photocatalysts and blue LED light (λmax=456 nm) (Table 2). The photocatalyst screening experiments revealed that the Ir photocatalysts tested here gave the desired C—O coupled product in 80-98% yield, while the Ru catalysts showed no reactivity.
aReaction conditions: In a N2-filled glovebox, 4-bromoacetophenone (0.4 mmol, 1.0 equiv), quinuclidine (0.44 mmol, 1.1 equiv), MeOH (1.6 mmol, 4 equiv), (MeN3)NiCl2 (2 mol %), photocatalyst (0.5 mol %) and a magnetic stir bar were added into 0.4 mL THF in a vial. The vial was irradiated with one blue LED lamp (50 W, 456 nm) under fan cooling. After 24 h, 1,3-benzodioxole (0.4 mmol) was added to the reaction mixture as a standard and the residue was analyzed by 1H NMR and GC-FID to determine the yield of C—O coupled product.
EPR and reactivity studies. Recent reports have proposed the oxidative addition to NiI to generate NiIII species is a key step in the C—O cross-coupling catalytic cycle, yet minimal evidence was provided and such a step has been underexplored experimentally. Our Ni catalysts have accessible NiII/I redox potentials, thus we aimed to probe both the reduction of NiII to a NiI species and the subsequent oxidative addition of Ar—Br to generate a NiIII intermediate by using X-band electron paramagnetic resonance (EPR) spectroscopy. For the EPR studies, 1b was used due to its better solubility vs 1a. Upon the reduction of 1b by 1 equivalent decamethylcobaltocene (CoCp*2) at −95° C. (
The NiIII species is believed to be a transient 6-coordinate (iPrN3)NiIII(PhAc)BrCl (3) complex generated through the oxidative addition of 4-bromoacetophenone to 2. Moreover, when 40 equiv 4-bromoacetophenone were added to 2 (
To further probe the role of various NiIII species in the C—O coupling reaction, we independently synthesized the (iPrN3)NiII(PhAc)Br complex 4 via oxidative addition of 4-bromoacetophenone to Ni(COD)2 in the presence of iPrN3 (
The effective magnetic moment μeff of 1.98 μb, determined using the Evans method, is consistent with a S=½ ground state for 5, as expected for a NiIII center. The rhombic EPR spectrum of 5 with gx=2.356, gy=2.158, gz=2.059 is significantly different than that of 3 (
The stability of 5 allowed us to investigate its reactivity. When 5 was reacted with 1 equiv tetraethylammonium chloride (TEACl,
We next probed the important step of ligand exchange with an alkoxide group. The addition at −80° C. of quinuclidine in MeOH to 5 generated a species assigned as the NiIII-aryl alkoxide complex [(iPrN3)NiIII(PhAc)(OMe)]+ (7), with a rhombic EPR signal with gx=2.326, gy=2.151, gz=2.027 and superhyperfine coupling to the one axial N (I=1) donor in the gz direction of Az(N)=19.4 G (
Upon warming up to room temperature, species 6 and 7 underwent C—O bond-forming reductive elimination, affording 4-methoxyacetophenone together with different amounts of acetophenone (Table 3), and consistent with a favorable reductive elimination from a NiIII species. Moreover, the addition of excess anionic ligands (Cl− or OMe− ) leads to increased yields of the C—O coupled product (Table 3) and faster decomposition of 6 and 7. We propose that coordination of an additional anionic ligand in the presence of excess base leads to the formation of a congested 6-coordinate NiIII center, due to the steric hindrance of the ethylene bridge that blocks the second axial coordination site (
Mechanistic Considerations. Finally, based on the photoredox/Ni dual catalytic studies under blue LED light, we evaluated the thermodynamic feasibility of the photocatalytic process in the C—O coupling reaction. A comparison of the redox potentials of the Ni complexes and photocatalysts implies that a reductive quenching pathway is not operating, as the observed production yields contradicts the trend of the oxidation strength of excited photocatalysts (Example 5). Instead, and oxidative quenching pathway, where the initial step is the single-electron reduction of NiII by the excited photocatalyst, is proposed to be operative, as this is in line with our results in which all photocatalysts with E(M+/*M) <−0.87 V afforded the C—O coupling product. By combining the insights obtained from EPR and reactivity studies and the photoredox/Ni dual catalysis, two photocatalytic mechanisms are proposed (
The (RN3)NiII complex is reduced to a NiI species by irradiation with purple LED light or the excited photocatalyst, which undergoes an oxidative addition with aryl halide to form a transient (RN3)NiIIIArBrX species. This NiIII species can then undergo a ligand exchange with the alcohol substrate in presence of excess base to generate the (RN3)NilIAr(OR)X species, which is then proposed to undergo a subsequent reductive elimination to yield the C—O coupled product and regenerate a (RN3)NiI species, completing the catalytic cycle. Regeneration of photocatalyst can be achieved by a SET reaction between NiI and the oxidized photocatalyst. Importantly, the use of the tridentate pyridinophane RN3 ligands generate sterically hindered 6-coordinate NiII centers due to the H atoms of the ethylene bridge and that are thus proposed to promote a rapid reductive elimination.
Conclusion. We herein report new tridentate pyridinophane RN3 ligands and their Ni complexes, which were employed in photocatalytic C—O cross-coupling catalytic and mechanistic studies. The (RN3)NiCl2 complexes were active photocatalysts for the C—O cross-coupling in the absence of a precious-metal photocatalyst. Employing these newly developed RN3 ligands allowed us to detect the critical but so far putative steps of the C—O cross-coupling catalytic cycle involving paramagnetic Ni species: the oxidative addition of an aryl halide to a NiI species to generate a NiIII species, the ligand exchange/transmetalation step at a NiIII center, and the C—O bond forming reductive elimination from a NiIII species. The present work suggests that these RN3 ligands can lead to the development of new Ni catalysts, and also are practical platform for detailed mechanistic studies of related Ni-catalyzed reactions.
aYields were determined using GC-FID with 1,3-benzodi oxole as a standard.
The following Examples are intended to illustrate the above invention and should not be construed as to narrow its scope. One skilled in the art will readily recognize that the Examples suggest many other ways in which the invention could be practiced. It should be understood that numerous variations and modifications may be made while remaining within the scope of the invention.
General procedure for the C—O cross-coupling reaction. In a N2-filled glovebox, 4-bromoacetophenone (0.4 mmol, 1.0 equiv), quinuclidine (0.44 mmol, 1.1 equiv), MeOH (1.6 mmol, 4 equiv), (MeN3)NiCl2 (2 mol %), and a magnetic stir bar were added into 0.4 mL THF in a vial. The vial was irradiated with one Kessil purple LED lamp (λmax=390 nm, max 52 W) under fan cooling. After 24 h, 1,3-benzodioxole (0.4 mmol) was added to the reaction mixture at a standard, and the reaction mixture was analyzed by 1H NMR in CDCl3 and GC-FID to determine the yield of C—O coupled product. Authentic 4-methoxyacetophenone was purchased from AK scientific and used to determine the retention time and response factor for GC-FID quantification.
General procedure for EPR detection of 2 and 3: In N2-filled glovebox, a MeOH solution of 1b was layered on top of a frozen PrCN solution of CoCp*2 and 4-bromoacetophenone in the EPR tube. The mixture was quickly frozen and taken outside of the glove box. The reaction mixture was mixed at −95° C., quickly frozen at 77 K, and then the sample was warmed up for ˜10 s to −95° C. to allow for a complete reaction.
General procedure for EPR detection of 5, 6, and 7: In N2-filled glovebox, an EPR tube was charged with 1:3 CH2Cl2:Toluene or PrCN solution of 5 and frozen at 77 K. A MeOH solution of TEACl, quinuclidine, or NaOMe was added over the frozen solution of 5. After taking out the EPR tube from the glovebox, an initial EPR spectrum was taken at 77 K (for 5). After a quick shake of the tube for 10 s at −95° C. (for 6 or 7), the sample was frozen at 77 K.
Data availability. Crystallographic data for the structures reported in this article have been deposited at the Cambridge Crystallographic Data Centre, under deposition numbers CCDC 2085516 (1a) and 2085517 (1b).
Physical Methods. 1H and 13C NMR spectra were recorded using a Bruker 400 MHz or 500 MHz spectrometer. UV-vis absorption spectra were recorded in CH2Cl2 in 1 cm quartz cuvettes using a Varian Cary 60 spectrophotometer. EPR spectra were recorded on a Bruker 10″ EMXPlus X-band Continuous Wave EPR spectrometer at 77 K. EPR spectra simulation and analysis were performed using Bruker WINEPR SimFonia program, version 1.25. The spin state of NiIII complex was determined using 1H NMR method of Evans at −40° C. Elemental analysis was carried out by the Microanalysis Laboratory at University of Illinois at Urbana-Champaign (UIUC) using an Exeter Analytical-Model CE440 CHN Analyzer. Cyclic voltammetry (CV) experiments were performed with a CHI 660D Electrochemical Analyzer using a three-electrode system in a nitrogen-filled glove box. A 3 mm diameter glassy-carbon electrode, Pt wire, and silver wire were used as working electrode, counter electrode, and pseudoreference electrode, respectively. Measurements were carried out in acetonitrile or dichloromethane solution with 0.1 M TBAPF6 as a supporting electrolyte at a scan rate of 0.1 V/s. Ferrocene was used as an internal standard, and potentials were referenced to the ferrocene/ferrocenium couple. The X-ray Photoelectron Spectroscopy (XPS) experiments were performed at the Materials Research Laboratory at UIUC using Kratos Axis ULTRA X-ray Photoelectron Spectrometer. Photocatalysis experiments were carried out using one Kessil lamp model PR160 blue LED (λmax=456 nm, max 50 W) or purple LED (λmax=390 nm, max 52 W).
Reactions were performed in ambient conditions unless otherwise stated. Solvents were purified prior to use by passing through a column of activated alumina using an MBraun solvent purification system. All starting materials and reagents, unless otherwise specified, were obtained from commercial sources and used without further purification. The starting material N-(tosyl)-2,11-diaza[3,3](2,6)pyridinophane (TsHN4) was synthesized following our published procedure (Wessel, A. J.; Schultz, J. W.; Tang, F.; Duan, H.; Mirica, L. M., Improved synthesis of symmetrically & asymmetrically N-substituted pyridinophane derivatives. Org. Biomol. Chem. 2017, 15, 9923-9931).
Refer to Scheme 2 for the following synthetic steps:
Synthesis of TsNON4 compound. A cold solution of NaNO2 270 mg in 3mL of water was added to a solution of TsHN4 100 mg in 2 mL of conc. HCl. The mixture was left overnight at room temperature. Next day, the yellowish white solids were filtered and washed with Et2O. Pale-yellow or white solid product were collected and dried. Yield: TsNON4 (83 mg, 77%) 1H NMR (500 MHz, DMSO-d6) δ 8.40 (t, J=7.8 Hz, 1H), 8.27 (t, J=7.8 Hz, 1H), 8.00 (d, J=7.8 Hz, 1H), 7.85 (d, J=7.8 Hz, 1H), 7.81-7.73 (m, 4H), 7.45 (d, J=8.0 Hz, 2H), 6.14 (s, 2H), 5.22 (s, 2H), 4.93 (s, 2H), 4.84 (s, 2H), 2.43 (s, 3H).
N-nitroso reduction reaction. Under N2, the TsNON4 compound (60 mg) was dissolved into a mixture of 4 M KOH 5 mL and ethanol 5 mL and heated under reflux (100-110° C.). After stirring for 1 h, the reaction mixture was cooled down to room temperature. Then solid sodium hydrosulfite (88 mg) was quickly added to the reaction mixture, and the reaction mixture was refluxed at 110° C. for 3 h. Then the mixture was cooled down and poured into 40 mL of water. The resulting solution was extracted with CH2Cl2 (3×25 mL). The combined organic layers were dried over MgSO4 and filtered. The clear solution was concentrated to dryness to give a white solid or yellowish white solid. Yield: TSN3 (34 mg, 63%) 1H NMR (400 MHz, Chloroform-d) δ 7.86-7.76 (m, 2H), 7.51 (t, J=7.5 Hz, 2H), 7.35 (d, J=8.0 Hz, 2H), 7.10 (d, J=7.6 Hz, 2H), 6.95 (d, J=7.6 Hz, 2H), 4.36 (s, 4H), 2.98 (s, 4H), 2.47 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 160.45, 153.37, 143.62, 137.42, 130.24, 130.03, 127.51, 127.24, 122.50, 121.77, 54.24, 39.35, 21.84. HRMS-ESI (m/z):[M+H]+ calcd for C21H12N3O2S, 380.1433; found 380.1440.
Synthesis of MeN3 ligand. Detosylation: Under N2, TsN3 300 mg was dissolved in 15 mL of 90% sulfuric acid. This mixture was stirred and refluxed at 110° C. for 2.5 hr. After cooling, the solution was basified with saturated KOH solution. The resulting solution was extracted with CH2Cl2, the organic layer was dried over anhydrous K2CO3 and MgSO4. The filtrate was dried to give an off-white solid. Yield: HN3 (130 mg, 73%) 1H NMR (400 MHz, Chloroform-d) δ 7.54 (t, J=7.5 Hz, 2H), 7.02 (dd, J=17.6, 7.6 Hz, 4H), 3.87 (s, 4H), 3.01 (s, 4H).
Methylation: Under N2, HN3 17 mg was dissolved in formic acid 2.5 mL and 40% formaldehyde solution 0.25 mL. The mixture was stirred and refluxed at 110° C. for overnight. After cooling the solution was treated with concentrated HCl 0.25 mL. After several minutes the solution was dried, and the residue was basified with NaOH solution and extracted with CH2Cl2. The organic layer was dried over anhydrous K2CO3 and MgSO4. The filtrate was dried to give slightly yellowish-white solid. Yield: MeN3 (17 mg, 94%) 1H NMR (400 MHz, Chloroform-d) δ 7.59 (t, J=7.6 Hz, 2H), 7.17-7.08 (m, 4H), 3.69 (s, 4H), 3.00 (s, 4H), 2.76 (s, 3H). 13C NMR (126 MHz, Chloroform-d) δ 160.26, 156.20, 136.95, 121.76, 120.95, 62.70, 62.67, 62.64, 47.23, 47.20, 47.18, 39.49. HRMS-ESI (m/z): [M+H]+ calcd for C15H17N3, 240.1501; found, 240.1492.
Synthesis of iPrN3 ligand. Isopropylation: HN3 (390 mg, 1.73 mmol), isopropylbromide (8.1 mL, 86.5 mmol, 50 equiv), anhydrous K2CO3 (2.87 g, 20.7 mmol, 12 equiv), and dry MeCN (60 mL) were charged into a 200 mL Schlenk flask with a magnetic stir bar. The reaction mixture was refluxed under N2 for 4 days. The solution was then cooled to room temperature, and the solvent was removed under reduced pressure. The residue was suspended in 100 mL of CH2Cl2 and then washed with 1M NaOH. The CH2Cl2 layer was isolated, and dried over MgSO4, evaporated and further dried under vacuum to give a pale yellow solid. Yield: iPrN3 (416 mg, 90%) 1H NMR (500 MHz, Chloroform-d) δ 7.51 (t, J=7.6 Hz, 2H), 7.03 (ddd, J=24.0, 7.6, 1.0 Hz, 4H), 3.74 (s, 4H), 3.23-3.18 (m, 1H), 3.00 (s, 4H), 1.26 (s, 6H). 13C NMR (126 MHz, Chloroform-d) δ 159.98, 157.96, 136.87, 121.53, 121.29, 57.32, 56.27, 39.09, 19.96. HRMS-ESI (m/z):[M+H]+ calcd for C17H21N3, 268.1814; found 268.1812
Synthesis of (TsN3)NiCl2 (1a). Inside of glovebox, Ni(DME)Cl2 (34 mg) and TsN3 (19 mg) were dissolved in 10 mL of CH2Cl2 at room temperature. The yellow mixture was stirred for 4.5 h and the yellow color was slowly turned to violet color. After 4.5 h, 10 mL of pentane was added, the precipitate was collected and dried under vacuum to afford violet solids. Yield: 34 mg, 45%. X-ray quality crystals were obtained by layering pentane and CH2Cl2 solution of the compound at −35° C.
Synthesis of (MeN3)NiCl2 (1b). Inside of glovebox, Ni(DME)Cl2 (29 mg) and MeN3 (32 mg) were dissolved in 10 ml of CH2Cl2 at room temperature. The yellow mixture was stirred for 4.5 h, slowly generating green precipitate. After 4.5 h, precipitate was collected and dried under vacuum to afford highly insoluble green solids. Yield: 44 mg, 91%. Insolubility of this product prevents spectroscopic characterization. X-ray quality crystals were obtained by layering pentane and MeOH solution of the compound at −35° C.
Synthesis of (iPrN3)NiCl2 (1c). Inside of glovebox, Ni(DME)Cl2 (27 mg, 0.12288 mmol) and iPrN3 (34 mg, 0.127 mmol) were dissolved in 10 mL of CH2Cl2 at room temperature. The yellow mixture was stirred for 4.5 h and yellow color was slowly turned to green color. After 4.5 h, green precipitate was collected and dried under vacuum to afford bright green solids. Yield: 47 mg, 96.9%. X-ray quality crystals were obtained by layering MeOH and CH2Cl2 solution of the compound at room temperature. 1H NMR (500 MHz, CD3OD) δ 68.82, 54.57, 42.18, 13.45. Elemental analysis: Found: C 43.76, H 4.77, N 8.61%; calculated C17H21Cl2N3Ni·1.2CH2Cl2: C 43.82, H 4.73, N 8.42%
Synthesis of (TsN3)NiMe2 (2a). To a stirred suspension of purple TsN3NiCl2 (55 mg) in THF at −50° C., 2 equiv of MeMgCl (80 μL) in THF solution was added. The mixture was stirred and slowly warmed up to room temperature over 3-4 h. The resulting red solution was completely dried and the residue was extracted with toluene. The resulting toluene solution was filtered through celite to remove black solids twice and the red filtrate was dried under vacuum to give an orange-red solid. Yield: TsN3NiCl2 (28 mg, 55%) 1H NMR (500 MHz, Benzene-d6) δ 7.69 (d, J=7.9 Hz, 2H), 7.22 (d, J=14.0 Hz, 2H), 7.06 (d, J=7.7 Hz, 2H), 6.84 (d, J=7.8 Hz, 2H), 6.51 (t, J=7.7 Hz, 2H), 6.09 (d, J=7.6 Hz, 2H), 5.24-5.07 (m, 2H), 4.93 (d, J=14.2 Hz, 2H), 2.87-2.68 (m, 2H), 1.97 (s, 3H), −0.01 (s, 6H).
Synthesis of (MeN3)NiMe2 (2b). To a stirred suspension of purple MeN3NiCl2 (48 mg) in THF at −50° C., 2 equiv of MeMgCl (90 μL) in THF solution was added. The mixture was stirred and slowly warmed up to room temperature over 3-4 h. The resulting red solution was completely dried and the residue was extracted with toluene. Resulting toluene solution was filtered through celite twice and filtrate was dried to give orange-red solid. Yield: TsN3NiCl2 (19 mg, 44%) 1H NMR (500 MHz, Benzene-d6) δ 7.24 (d, J=14.0 Hz, 2H), 6.42 (t, J=7.6 Hz, 2H), 6.08 (d, J=7.6 Hz, 2H), 5.98 (d, J=7.6 Hz, 2H), 5.22 (d, J=9.4 Hz, 2H), 3.85 (d, J=14.0 Hz, 2H), 2.76 (d, J=9.7 Hz, 2H), 1.66 (s, 3H), 0.13 (d, J=1.5 Hz, 6H). 13C NMR (126 MHz, Benzene-d6) δ 158.82, 156.76, 133.70, 122.07, 122.00, 62.72, 38.15, 33.56, −12.06.
Synthesis of (iPrN3)Ni(PhAc)Br (4). Inside of glovebox, Ni(COD)2 (48 mg, 0.17 mmol), 4-bromoacetophenone (35 mg, mmol) and iPrN3 (47 mg, 0.18 mmol) were dissolved in 3 mL of THF at room temperature. After 10 min, 2 mL of Pentane was added. The mixture was stirred for overnight and brick red precipitate was collected and dried under vacuum. Yield: 52 mg, 58%. 1H NMR (500 MHz, CD2Cl2, −40° C.) δ 8.01-7.96 (m, 1H), 7.36 (d, J=6.9 Hz, 1H), 7.30 (d, J=8.0 Hz, 1H), 7.25 (t, J=7.5 Hz, 1H), 7.13 (d, J=7.9 Hz, 1H), 6.99 (d, J=7.5 Hz, 1H), 6.93 (d, J=8.0 Hz, 1H), 6.79 (d, J=7.7 Hz, 1H), 6.34 (s, 1H), 5.96 (s, 1H), 5.05 (d, J=16.6 Hz, 1H), 4.51 (d, J=12.8 Hz, 2H), 4.39 (t, J=16.1 Hz, 2H), 3.94 (d, J=14.1 Hz, 1H), 3.86 (d, J=12.5 Hz, 1H), 2.39 (s, 3H), 2.06 (d, J=5.6 Hz, 3H), 1.54 (d, J=5.7 Hz, 3H).
Synthesis of [(iPrN3)NiIII(PhAc)(Br)]+ (5). 10 mL dichloromethane solution of one equivalent acetylferrocenium hexafluorophosphate (AcFcPF6, 22 mg, 0.059 mmol) was added to solids of (iPrN3)Ni(PhAc)Br (31 mg, 0.059 mmol) at −35° C. and the resulting solution was stirred for 20 min. The volume of the solution was reduced to 5 mL and 10 mL of diethyl ether was added to precipitate the solids. The pink precipitated was filtered and washed with diethyl ether, and dried under vacuum. Yield: 32 mg, 81%. Evans method (CH2Cl2): μeff=1.98 μb. Elemental analysis: Found: C 43.35, H 4.31, N 7.06%; calculated C25H28BrF6N3NiOP: C 44.81, H 4.21, N 6.27% Several attempts to obtain elemental analysis data proved unsuccessful, likely due to its decomposition during handling. Although these results are slightly outside the range viewed as establishing analytical purity, they are provided to illustrate the best values obtained to date.
General procedure for the etherification reaction: In a nitrogen-filled glovebox, 4-Bromoacetophenone (0.4 mmol, 1.0 equiv.), quinuclidine (0.44 mmol, 1.1 equiv.), MeOH (1.6 mmol, 4 equiv.), (MeN3)NiCl2 (2 mol %), and a magnetic stir bar were added into 0.4 mL of THF in a vial. The vial was irradiated with one Kessil Purple LED (λmax=390 nm, max 52 W) under fan cooling. After 24 h, 1,3-benzodioxole (0.4 mmol) was added to the reaction mixture. The residue was analyzed by 1H NMR in CDCl3 and GC-FID to give the yield of the reaction. The authentic product 4-Methoxyacetophenone was purchased from AK scientific and used to determine retention time and a response factor for GC-FID quantification.
aThe dark entry was covered with foil and placed under Purple LED.
MeN3 + Ni(DME)Cl2
aGeneral reaction condition (1M in THF, Ni catalyst 2 wt %) was used.
General procedure for the etherification reaction: In a nitrogen-filled glovebox, 4-Bromoacetophenone (0.4 mmol, 1.0 equiv.), quinuclidine (0.44 mmol, 1.1 equiv.), MeOH (1.6 mmol, 4 equiv.), (MeN3)NiCl2 (2 mol %), photocatalyst (0.5 mol %) and a magnetic stir bar were added into 0.4 mL of THF in a vial. The vial was irradiated with one Kessil Blue LED (λmax=456 nm, max 52 W) under fan cooling. After 24 h, 1,3-benzodioxole (0.4 mmol) was added to the reaction mixture. The residue was analyzed by 1H NMR in CDCl3 and GC-FID to give the yield of the reaction. The authentic product 4-Methoxyacetophenone was purchased from AK scientific and used to determine retention time and a response factor for GC-FID quantification.
General procedure for the etherification reaction: In a nitrogen-filled glovebox, 4-bromoacetophenone (0.4 mmol, 1.0 equiv.), quinuclidine (0.44 mmol, 1.1 equiv.), MeOH (1.6 mmol, 4 equiv.), (MeN3)NiCl2 (2 mol %), and a magnetic stir bar were added into 0.4 mL of THF in a vial. The vial was irradiated with one Kessil purple LED (λmax=390 nm, max 52 W) under fan cooling. After 24 h, 1,3-benzodioxole (0.4 mmol) was added to the reaction mixture. The residue was analyzed by 1H NMR in CDCl3 and GC-FID to give the yield of the reaction. The authentic product 4-Methoxyacetophenone was purchased from AK scientific and used to determine retention time and a response factor for GC-FID quantification.
aThe dark entry was covered with foil and placed under purple LED.
aThe average product yield from three independent experiments
aThe average product yield from three independent experiments
aThe average product yield from three independent experiments
aGeneral reaction condition (1M in THF, Ni catalyst 2 wt %) was used
bThe average product yield from three independent experiments
MeN3 + Ni(DME)Cl2
aGeneral reaction condition (1M in THF, Ni catalyst 2 wt %) was used
bThe average product yield from three independent experiments
aAll redox and excited-state redox potential were corrected from known experimental values using conversion constants for redox potentials, and reported vs SCE.
birreversibility of the peak prevents accurate assignment of the redox potential.
Based on photoredox/Ni dual catalysis with blue LED experiment results, we evaluated thermodynamic feasibility of photocatalysts in the C—O coupling reaction for additional mechanistic insight (Table 13). Regarding photoredox/Ni dual catalysis, two distinct mechanisms can be considered: a reductive quenching or an oxidative quenching mechanism.
First of all, the mechanism composed of photocatalyst reductive quenching M/*M/M−/M cycle and Ni0NiIINiIIINiINi0 cycle has been considered. In our results, both of strong oxidant [Ir(dF(CF3)2ppy)(dtbbpy)]PF6 (E(*IrIII/IrII)=+1.21 V vs SCE) and weak oxidant fac-Ir(ppy)3 (E(*IrIII/IrII)=+0.31 V vs SCE) successfully generated the desire C—O coupled product. In this scenario, the NiII species involved as a catalytic intermediate would be (RN3)NiIIAr(OR), as proposed by MacMillan et al (Nature 2015, 524, 330). Considering redox potentials of Ni complexes and photocatalysts (Ir and Ru complexes), it implies that the reductive quenching pathway involving [Ru(phen)3]Cl2 (E(*RuII/RuI)=+0.82 V vs SCE) is also thermodynamically feasible, and therefore could mediate the reaction. However, only a trace amount of product was observed with [Ru(phen)3]Cl2, and the observed production yields contradicts the trend of oxidation strength of excited photocatalysts ([Ir(dF(CF3)2ppy)(dtbbpy)]PF6>[Ru(phen)3]Cl2>fac-Ir(ppy)3).
Therefore, we propose that the reductive quenching cycle might not be operating in our system. The other possibility includes oxidative quenching of photocatalyst *M/M+/M/*M cycle and NiII/NiI/NiIII/NiI/NiII cycle. In this case, the key step in the catalytic cycle is the single-electron reduction of Ni catalyst by the excited photocatalyst. As seen in our results, all the photocatalysts with excited state reduction potential E(M+/*M)<−0.87 V successfully afforded a significant amount of C—O coupling product. Although our experimentally obtained redox potential of NiII/I (−0.82 V vs SCE), which is slightly less negative than that of [Ru(phen)3]Cl2 (E(RuIII/*RuII)=−0.87 V vs SCE), suggests SET process between Ni and *Ru is thermodynamically feasible, we believe that irreversibility of NiII/I peak prevents correct assignment of the reduction potential and values are fall within the margin of error.
Taken together, we postulate the preferred mechanistic pathway may not involve a NiII to NiIII oxidation by the excited photocatalyst, instead would be involving a SET NiII to NiI reduction process. We note that for some photocatalysts (such as fac-Ir(ppy)3), regeneration of photocatalyst (M+ to M) can also occur in concurrence with quinuclidine oxidation (estimated oxidation potential Ep=+1.09 V vs SCE).
This technology presents the novel synthetic approach of a new class of RN3 ligands featuring a chemically robust macrocycle with a flexible chelating arm. Utilization of the N-nitroso reduction reaction in pyridinophane chemistry enables the design of more elaborate ligand structures, not readily accessible through known synthetic routes. The reaction precursor (TsHN4) is a known chemical that can be easily synthesized by following our reported procedure. The N-nitroso reduction conditions are mild, suggesting a broad functional group tolerance. As all of the reaction steps toward the target molecules RN3 are not requiring extensive purification steps, the yield of each step is fairly high. This discovery of this novel synthetic route would enable developing more diverse structures of ligands, by further functionalization or starting from different chemical precursors.
Unlike commonly used linear tridentate N3 type ligands, these new macrocyclic RN3 ligands are fairly rigid to enforce facial capping coordination, while also containing a flexible arm that can control the reactivity of the metal center. As such, this unique RN3 can be a useful ligand structure for a wide field of coordination chemistry. In addition, the use of N-donor ligands in which the pyridyl groups are perpendicular to the equatorial plane of the metal center have never been used in catalysis to date.
Synthesis of various transition metal complexes which would provide desired properties depends on the field of application. We are showing herein the synthesis of various Nickel complexes, for which results show they are very efficient catalysts for photoredox catalysis for the formation of C—C and C-heteroatom bonds.
In our preliminary study, we discovered that Ni complexes supported by newly developed ligand MeN3 could successfully catalyze the cross-coupling reaction of 4-bromoacetophenone with methanol under irradiation with purple LED light in the absence of additional photocatalysts, or irradiation with blue LED light in the presence of additional photocatalysts. Visible-light photocatalysis or photoredox catalysis has recently received increasing attention from chemists due to its wide application in organic synthesis and its significance for sustainable chemistry, highlighting the mild reaction conditions by using convenient sources of light.
While specific embodiments have been described above with reference to the disclosed embodiments and examples, such embodiments are only illustrative and do not limit the scope of the invention. Changes and modifications can be made in accordance with ordinary skill in the art without departing from the invention in its broader aspects as defined in the following claims.
All publications, patents, and patent documents are incorporated by reference herein, as though individually incorporated by reference. No limitations inconsistent with this disclosure are to be understood therefrom. The invention has been described with reference to various specific and preferred embodiments and techniques. However, it should be understood that many variations and modifications may be made while remaining within the spirit and scope of the invention.
This application claims priority under 35 U.S.C. § 119(e) to U.S. Provisional Patent Application No. 63/215,131, filed Jun. 25, 2021, which is incorporated herein by reference.
| Number | Date | Country | |
|---|---|---|---|
| 63215131 | Jun 2021 | US |
